孕期糖尿病:关于查,诊断和管理的最新情况
Joshua S Will1, Holly Crellin1
1Uniformed Services University of the Health Sciences, Bethesda, Maryland.
American family physician
|September 19, 2023
概括
孕期糖尿病 (GDM) 的管理包括改变生活方式,如果需要,胰岛素. 早期查和适当的分娩时间是GDM孕妇健康结果的关键.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 孕期糖尿病 (GDM) 在美国越来越普遍.
- GDM增加了手术分娩,高血压疾病和新生儿不良后果的风险.
- 超重/肥胖个体可以通过妊娠前的减肥和生活方式改变来预防GDM.
研究的目的:
- 概述GDM目前的管理策略.
- 强调早期查和血糖控制的重要性.
- 提供关于分娩时间和产后风险降低的指导.
主要方法:
- 审查目前的证据和GDM管理的临床指南.
- 讨论查,改变生活方式,药物治疗 (胰岛素) 和胎儿监测.
- 对分娩时间建议和产后护理的分析.
主要成果:
- 第一个三个月的查可以确定先前存在的糖尿病和早期的GDM.
- 改变生活方式是治疗的第一线;如果需要,胰岛素是推的第一线药物.
- 胎儿监测和对宏的评估对于指导分娩决策至关重要.
- 在39到40周之间分娩优化了母亲和胎儿的结果.
- 产后风险降低策略包括改变生活方式,母乳养和甲胺.
结论:
- 有效的GDM管理可以降低并发症的风险.
- 推基于葡萄糖控制方法的个性化分娩时间.
- 患有GDM的患者在产后患有明显糖尿病的风险增加.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes
980
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
980
Diabetes: Management and Pharmacotherapy
309
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
309
Diabetes: Symptoms, Diagnosis, and Complications
581
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
581
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230


